Hypertriglyceridemia News

Q&A: Targeting hypertriglyceridemia reduces CV events - Healio



Q&A: Targeting hypertriglyceridemia reduces CV events 
Healio
There are some novel medications that are currently in clinical trials, especially for some of the severe states of hypertriglyceridemia, but probably the most effective treatment at this point is through diet and exercise: avoiding simple ...

 


DHA Reduces Fasting Triglycerides in HIV With Hypertriglyceridemia - Infectious Disease Advisor



Infectious Disease Advisor
 
DHA Reduces Fasting Triglycerides in HIV With Hypertriglyceridemia 
Infectious Disease Advisor
Docosahexanoic acid (DHA) supplementation in patients with HIV receiving combination antiretroviral therapy (cART) lowered triglyceride levels significantly, according to a study in Clinical Nutrition.1. Researchers conducted a double-blind, ...

 


Hypertriglyceridemia Market Research Report 2017 to 2025 - Medgadget (blog)



Hypertriglyceridemia Market Research Report 2017 to 2025 
Medgadget (blog)
Hypertriglyceridemia- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for ...

and more » 


Triglycerides, HDL critical in controlling cardiometabolic risk - Healio



Triglycerides, HDL critical in controlling cardiometabolic risk 
Healio
Plasma triglycerides are inversely related to HDL, even though patients with hypertriglyceridemia often think that their HDL will be low, according to the presentation. The inverse relationship is related to cholesterol-enriched HDL and its dependence ...

 


Survey Results Confirm Difficulty of Living with FCS - Rare Disease Report (blog)



Rare Disease Report (blog)
 
Survey Results Confirm Difficulty of Living with FCS 
Rare Disease Report (blog)
The carriers ? the parents ? often have a milder hypertriglyceridemia. They have a little bit of this lipedema, but they don't have all the qualities of the people who get the full-blown disorder have, such as recurrent pancreatitis. The disorder is ...

 


Acasti Pharma Announces Issuance of Common Shares in Payment ... - Marketwired (press release)



Acasti Pharma Announces Issuance of Common Shares in Payment ... 
Marketwired (press release)
LAVAL, QUÉBEC--(Marketwired - Oct. 4, 2017) - Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST)(TSX VENTURE:ACST) announces that in ...
Acasti Pharma, Inc. (NASDAQ:ACST) Has Wide Low-High Trading ... First News 24

all 10 news articles » 


Early Data: IL-10 + Nivolumab May Improve Efficacy in Renal Cancer - Clinical Oncology News



Clinical Oncology News
 
Early Data: IL-10 + Nivolumab May Improve Efficacy in Renal Cancer 
Clinical Oncology News
The most common grade 3/4 AEs included anemia (10 patients), thrombocytopenia (seven patients) and hypertriglyceridemia (six patients). Two patients had reversible cytokine release syndrome with splenomegaly and increased immune-mediated red ...

 


Amarin and HLS Therapeutics Announce Agreement to ... - GlobeNewswire (press release)



Amarin and HLS Therapeutics Announce Agreement to ... 
GlobeNewswire (press release)
BEDMINSTER, N.J., DUBLIN, Ireland, and TORONTO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) and HLS Therapeutics ...

and more » 


VIDEO: Lifestyle modifications may improve HDL levels - Healio



Healio
 
VIDEO: Lifestyle modifications may improve HDL levels 
Healio
?We have no solid clinical trial evidence of when to treat hypertriglyceridemia, how low should we go and if, in fact, there's benefit to follow.? According to Eckel, although there is little information on how much lifestyle modification affects HDL ...

 


An Upcoming Discussion With A Cardiologist On Amarin's Vascepa And Its Potential In Treating Hypertriglyceridemia - Seeking Alpha



Seeking Alpha
 
An Upcoming Discussion With A Cardiologist On Amarin's Vascepa And Its Potential In Treating Hypertriglyceridemia 
Seeking Alpha
With Amarin's (AMRN) REDUCE-IT for Vascepa (icosapent ethyl) nearly complete, we're getting an expert's view of just how effective Vascepa is in treating hypertriglyceridemia. The goal is to give investors a better understanding of the success of ...